References
1. Jennette JC FR, Bacon PA, Basu N,
Cid MC, Ferrario F, Flores-Suarez LF, et al. 2012 revised international
Chapel Hill consensus conference nomenclature of vasculitides. Arthritis
Rheum 2013; 65 : 1–11.
2. McCarthy HJ, Tizard EJ. Clinical
practice: Diagnosis and management of Henoch-Schonlein purpura. European
journal of pediatrics 2010; 169 : 643-50.
3. Aktas B TP, Kurt OK, Ensari A,
Demirer T. Severe Henoch-Schönlein Purpura Induced by Cytarabine. Ann
Pharmacother 2009 43 : 792–3.
4. Watanabe T. Henoch-Schonlein
purpura following influenza vaccinations during the pandemic of
influenza A (H1N1). Pediatric nephrology 2011; 26 : 795-8.
5. Jariwala S VN, Shliozberg J.
Henoch-Schonlein purpura after hepatitis A vaccination. Ann Allergy
Asthma Immunol 2011; 107 : 180–1.
6. Hetland LE, Susrud KS, Lindahl KH,
Bygum A. Henoch-Schonlein Purpura: A Literature Review. Acta
dermato-venereologica 2017; 97 : 1160-6.
7. Heineke M. H, Ballering, A.V, Jamin
A, Ben Mkaddem, S, Monteiro, R. C, Van Egmond M. New insights in the
pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura).
Autoimmunity reviews 2017; 16 : 1246-53.
8. Kurotobi S, Kawakami N, Honda A,
Matsuoka T, Hara T, Nagai T, et al. Impaired vascular
endothelium-dependent relaxation in Henoch-Schonlein purpura. Pediatric
nephrology 2004; 19 : 138-43.
9. Dursun I, Dusunsel R, Poyrazoglu
HM, Gunduz Z, Patiroglu T, Ulger H, et al. Circulating endothelial
microparticles in children with Henoch-Schonlein purpura; preliminary
results. Rheumatology international 2011; 31 : 1595-600.
10. Van der Poll T, Parker RI.
Platelet Activation and Endothelial Cell Dysfunction. Critical care
clinics 2020; 36 : 233-53.
11. Culic S JR. Purpura
anaphylactoides (Schöenlein-Henoch) in childhood as the consequence of
immune vasculitis and immune thrombocytopathia. Thromb Haemost Abstracts
XVI Congress of the International Society on Thrombosis and Haemostasis
Florence, Italy (Suppl)June 1997: p. 272.
12. Edekmann CM Jr BJ, Meadow SR,
Spitter A, Travis LB. Schonlein-Henoch Syndrome. In: Pediatric Kidney
Disease, (2nd edition), Little, Brown and Company 1992: 1525-33.
13. Culic S JR, Metlicic V,
Paukovic-Sekulic B, Resic B, Culic V, Kuljis D, Primorac D. Platelet
function analysis in children with Schonlein–Henoch syndrome. Arch Med
Res 2001; 32 : 268–72.
14. Mishkova R. KK, Petrova E.
Hemostatic disorders in patients with Schoenlein–Henoch syndrome, in
Russian. Klin Med (Mosk) 1990; 68 : 47-9.
15. Ozen S, Ruperto N, Dillon MJ,
Bagga A, Barron K, Davin JC, et al. EULAR/PRES endorsed consensus
criteria for the classification of childhood vasculitides. . Ann Rheum
Dis 2006; 65 : 936-41.
16. Shi X, Li WC, Mo LJ, Li XH, Luo
YZ, Qin LQ, et al. Altered mean platelet volume in children with
Henoch-Schonlein purpura and its association with disease activity.
Annals of clinical biochemistry 2018; 55 : 368-72.
17. Boros G GL, Sámsik J, Nagy J,
Hámori A, Deák G . Blood coagulation abnormalities in the
Schönlein-Henoch syndrome in adults. Acta Med Acad Sci Hung 1979;36 : 151-66.